Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PFx Biotech is a Portuguese biotechnology company specializing in the production of bioactive human milk proteins through precision fermentation. The company's primary focus is on developing human-identical lactoferrin to enhance infant formula and specialized nutrition products. By utilizing advanced microbial engineering, PFx Biotech aims to provide sustainable and scalable alternatives to bovine-derived proteins, ensuring better health outcomes for infants and adults. Their platform focuses on high-purity, functional proteins that mimic the complex nutritional profile of human breast milk. The company is currently scaling its production processes to meet the growing demand for high-quality nutritional ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PFx Biotech.